EME commissions Batch Plant for Pharmaceutical Glass Tubing in China

In the 4th quarter of 2020, German based SCHOTT AG, started up a greenfield production plant for pharmaceutical glass tubing in Zhejiang Province, People's Republic of China. The new plant will produce high-quality borosilicate glass tubing – the base material for pharmaceutical packaging such as vials, ampoules, syringes and cartridges, which the vast majority of COVID-19 vaccine projects rely upon.

EME, with the support of our daughter company Shanghai Precision, supplied the Batch Plant incl. Batch Transport and Cullet Return System on a turn-key basis, including building, process equipment and the control system. The batch plant is designed for several furnaces and different glass types.

For the process technology EME adhered to the strict SCHOTT requirements in the dosing, weighing and mixing areas in order to obtain SCHOTT's highest quality pharmaceutical glass.

21.01.2021,

News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.